The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125687011 12568701 1 I 20160502 20160706 20160719 20160719 EXP US-ROCHE-1791689 ROCHE 46.00 YR Y 0.00000 20160719 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125687011 12568701 1 PS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Intravenous (not otherwise specified) U 50722
125687011 12568701 2 SS GANCICLOVIR. GANCICLOVIR 1 Unknown U 19661
125687011 12568701 3 SS VANCOMYCIN VANCOMYCIN 1 Unknown U 0
125687011 12568701 4 SS MORPHINE MORPHINE 1 Unknown U 0
125687011 12568701 5 SS DILAUDID HYDROMORPHONE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0.5-1 MG EVERY 4 HOURS AS NEEDED (PRN) U 0
125687011 12568701 6 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) U 0
125687011 12568701 7 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown U 0 2 MG/KG
125687011 12568701 8 SS PREDNISONE. PREDNISONE 1 Oral U 0 QD
125687011 12568701 9 SS CYCLOSPORIN CYCLOSPORINE 1 Intravenous (not otherwise specified) MOST RECENT DOSE PRIOR TO SAE: 09/MAY/2016 U 0 INFUSION
125687011 12568701 10 SS INCB039110 INVESTIGATIONAL PRODUCT 1 Oral MOST RECENT DOSE PRIOR TO SAE: 09/MAY/2016 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125687011 12568701 1 Prophylaxis against graft versus host disease
125687011 12568701 2 Product used for unknown indication
125687011 12568701 3 Product used for unknown indication
125687011 12568701 4 Product used for unknown indication
125687011 12568701 5 Product used for unknown indication
125687011 12568701 6 Graft versus host disease
125687011 12568701 8 Graft versus host disease
125687011 12568701 9 Prophylaxis against graft versus host disease
125687011 12568701 10 Graft versus host disease

Outcome of event

Event ID CASEID OUTC COD
125687011 12568701 DE
125687011 12568701 HO
125687011 12568701 LT
125687011 12568701 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125687011 12568701 Acidosis
125687011 12568701 Acute kidney injury
125687011 12568701 Atrial fibrillation
125687011 12568701 Hypotension
125687011 12568701 Immunosuppressant drug level increased
125687011 12568701 Infection
125687011 12568701 Melaena
125687011 12568701 Multiple organ dysfunction syndrome
125687011 12568701 Pancytopenia
125687011 12568701 Pulmonary oedema
125687011 12568701 Respiratory failure
125687011 12568701 Thrombocytopenia
125687011 12568701 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125687011 12568701 1 20160425 0
125687011 12568701 4 20160510 0
125687011 12568701 5 20160510 0
125687011 12568701 6 20160426 20160509 0
125687011 12568701 8 20160422 20160426 0
125687011 12568701 9 20160425 0
125687011 12568701 10 20160505 0